WT1 PEPTIDE-BASED CANCER IMMUNOTHERAPY

被引：0
|
作者：
Sugiyama, H. [1 ]
机构：
[1] Osaka Univ, Dept Funct Diagnost Sci, Grad Sch Med, Suita, Osaka 565, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [31] PEPTIDE-BASED IMMUNOTHERAPY IN SARCOMA
    Todorova, Roumiana
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2017, 70 (12): : 1689 - 1700
  • [32] Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy
    Chisato Yokota
    Naoki Kagawa
    Koji Takano
    Yasuyoshi Chiba
    Manabu Kinoshita
    Noriyuki Kijima
    Yusuke Oji
    Yoshihiro Oka
    Haruo Sugiyama
    Akihiro Tsuboi
    Shuichi Izumoto
    Haruhiko Kishima
    Naoya Hashimoto
    Cancer Immunology, Immunotherapy, 2022, 71 : 189 - 201
  • [33] Evidence for WT1 as a potential target for immunotherapy of lethal ovarian cancer
    Carter, Julia H.
    Deddens, James A.
    Mueller, Gretchen
    Lewis, Thomas G.
    Dooley, Mariah K.
    Pemberton, Jackson O.
    Douglass, Larry E.
    CANCER RESEARCH, 2017, 77
  • [34] Cancer immunotherapy targeting Wilms' tumor gene WT1 product
    Sugiyama, H
    EXPERT REVIEW OF VACCINES, 2005, 4 (04) : 503 - 512
  • [35] Cancer immunotherapy targeting Wilms' tumor gene WT1 product
    Oka, Y
    Udaka, K
    Tsuboi, A
    Elisseeva, OA
    Ogawa, H
    Aozasa, K
    Kishimoto, T
    Sugiyama, H
    JOURNAL OF IMMUNOLOGY, 2000, 164 (04): : 1873 - 1880
  • [36] Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy
    Yokota, Chisato
    Kagawa, Naoki
    Takano, Koji
    Chiba, Yasuyoshi
    Kinoshita, Manabu
    Kijima, Noriyuki
    Oji, Yusuke
    Oka, Yoshihiro
    Sugiyama, Haruo
    Tsuboi, Akihiro
    Izumoto, Shuichi
    Kishima, Haruhiko
    Hashimoto, Naoya
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (01) : 189 - 201
  • [37] Novel peptide-based HIV-1 immunotherapy
    Sommerfelt, MA
    Nyhus, J
    Sorensen, B
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (03) : 349 - 361
  • [38] Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines
    Mohit, Elham
    Hashemi, Atieh
    Allahyari, Mojgan
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (07) : 927 - 961
  • [39] Peptide-Based Nanomaterials for Tumor Immunotherapy
    Li, Lingyun
    Ma, Bing
    Wang, Weizhi
    MOLECULES, 2021, 26 (01):
  • [40] Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
    Oka, Y
    Tsuboi, A
    Taguchi, T
    Osaki, T
    Kyo, T
    Nakajima, H
    Elisseeva, OA
    Oji, Y
    Kawakami, M
    Ikegame, K
    Hosen, N
    Yoshihara, S
    Wu, F
    Fujiki, F
    Murakami, M
    Masuda, T
    Nishida, S
    Shirakata, T
    Nakatsuka, S
    Sasaki, A
    Udaka, K
    Dohy, H
    Aozasa, K
    Noguchi, S
    Kawase, L
    Sugiyama, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (38) : 13885 - 13890
12345